ReviewJournal of arrhythmia2025
Catheter ablation using pulsed-field energy: Advantages and limitations compared with conventional energy.
Review in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of pulsed field ablation and very high-power short-duration ablation for atrial fibrillation: a meta-analysis.Frontiers in cardiovascular medicine · 2026Pooled it
- Indirect treatment comparison of two pulsed field ablation systems for the treatment of persistent atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Trial
- Unexpected Right Atrial Crossing of the Sphere-9 Catheter Despite Stable Left Atrial Sheath Position.Journal of arrhythmia · 2026Article
- Association Between the Change in Interleukin-6 Levels and Early Recurrence of Atrial Fibrillation: A Comparison of Pulsed Field Ablation and Radiofrequency Ablation.Journal of arrhythmia · 2026Article
- Epicardial Connection as a Resource of Atrial Fibrillation Recurrence After Pulsed Field Ablation: A Case Report.Clinical case reports · 2026Article
- Pulsed Field Ablation of Macro-Reentrant Atrial Tachycardia Involving the Persistent Left Superior Vena Cava.Pacing and clinical electrophysiology : PACE · 2026Article
- Late-Onset Suspected Coronary Vasospasm Following Focal Monopolar Pulsed-Field Ablation for Atrial Fibrillation.Journal of cardiovascular electrophysiology · 2026Article
- Feasibility and Safety of High-Power Settings for Electrical Isolation of the Superior Vena Cava Using a Catheter Capable of Local Impedance and Contact Force Monitoring.Journal of arrhythmia · 2026Article
- Use of a multi-electrode circular pulse field ablation catheter for selective lesion delivery and ablation of focal atrial tachycardia.HeartRhythm case reports · 2026Article
- Pulsed field ablation using a large-tip focal contact force-sensing catheter with 3-dimensional mapping integration: 12-Month outcomes from the OMNY-AF pilot phase.Heart rhythm O2 · 2026Article
- Epicardial Pulsed Field Ablation for Bachmann Bundle-Mediated Atrial Tachycardia: Expanding Indications and Identifying Limitations.JACC. Case reports · 2026Article
- Pulsed Field Ablation for Atrial Fibrillation in Japan: Current Status and Future Perspectives.Circulation reports · 2026Review
- Intravascular hemolysis after pulsed field ablation for atrial fibrillation: A comparative analysis of 3 systems.Heart rhythm O2 · 2026Article
- Beyond the Pulmonary Veins: The Influence of Pulsed Field Ablation on the Superior Vena Cava.Journal of arrhythmia · 2025Article
- Mapping Atrial Tachycardia Post-Pulmonary Vein Isolation Using the PulseSelect Catheter and Ensite NavX.Journal of arrhythmia · 2025Article
- Feasibility of Hybriding Very High-Power Short-Duration and Ablation Index-Guided Pulmonary Vein Isolation.Journal of arrhythmia · 2025Article
- Outcomes With Pulsed Field Ablation Versus Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: A Meta-Analysis.Journal of arrhythmia · 2025Article
- Biophysics and Clinical Effectiveness of Irreversible Electroporation for Catheter Ablation of Atrial Fibrillation.Journal of cardiovascular development and disease · 2025Review
- Pulsed-field ablation to isolate common inferior pulmonary veins in a patient with recurrent atrial fibrillation.Journal of arrhythmia · 2025Article
- Catheter ablation using pulsed-field energy: Advantages and limitations compared with conventional energy.Journal of arrhythmia · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) poses significant risks of heart failure and stroke, emphasizing effective treatment. Catheter ablation using thermal energy sources, such as radiofrequency or cryoballoon ablation, has shown greater success in maintaining sinus rhythm compared with drug therapy. However, thermal ablation (TA) is associated with serious complications, such as atrial-esophageal fistula, phrenic nerve palsy, and pulmonary vein stenosis. Pulsed-field ablation (PFA) is an emerging ablation energy source that uses electroporation to selectively target cardiac tissue while sparing adjacent structures such as nerves and blood vessels. Two randomized controlled trials have demonstrated that PFA is comparable to TA in both efficacy and safety at a 1-year follow-up and had shorter procedure times. A review of six meta-analyses consistently showed shorter procedural times for PFA across all studies. Additionally, three out of the four recent studies with large samples reported lower recurrence rates with PFA. Regarding complication rates, four out of four studies showed lower incidences of phrenic nerve injury with PFA, and two out of three studies reported lower rates of esophageal injury with PFA. However, four out of four studies indicated higher incidences of cardiac tamponade with PFA, highlighting the need for caution among early-career operators. Furthermore, careful monitoring is required considering the possible unforeseen complications specific to PFA and the lack of long-term follow-up data. Despite these concerns, PFA shows promise as a safer, more effective, and efficient alternative to TA for AF, particularly as operator experience and device technology continue to advance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.